Three Big Questions for Stage 3 & Patient Engagement
Chilmark Research
JANUARY 17, 2014
For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. Below are three questions Chilmark is keenly tracking throughout the remainder of 2014: What Constitutes PGHD?
60 
Let's personalize your content